The new rules introduce a fast-track notification route, enabling quicker starts for lower-risk trials and maintaining safety ...

The lifecycle of a medical device is under renewed regulatory and commercial scrutiny. Although lifetime expectations are not ...

The 9% growth in 2025 could signal that the country is on track to become a more attractive destination for pharamceutical ...

The data was revealed as a UK delegation headed by MHRA chief executive Lawrence Tallon attended the J PM Healthcare ...

The MHRA is now setting out the next phase of reforms for 2026, aimed at helping patients access new cutting-edge treatments ...

A new £50 million initiative aims to cut the length of time novel medicines spend in clinical trials, enabling patients to benefit from new treatments much sooner.

The U.K.’s Medicines and Healthcare products Regulatory Agency (MHRA) has introduced several new measures to make it easier to run clinical trials in the country, marking the first time in 20 years ...

Last week the Regulation on Clinical Trials (“CTR”) finally became effective in the European Union (“EU”) and replaced the prior Clinical Trials Directive 2001/20 (“CTD”). The CTR was adopted in 2014 ...

In the dark days of 2020, amid the global race for a COVID-19 vaccine, the UK showcased its world-class expertise in medical research. The swift development of the Oxford-AstraZeneca vaccine, ...

A large multicenter clinical trial led by King's College London with 150 children and adolescents has shown that a device ...

The key element of the agreement is confirmation that UK pharmaceutical exports to the US will face a preferential tariff ...